Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Epigenetics and DNA Methylation, Chromatin Remodeling and Cancer, Histone Deacetylase Inhibitors Research, and Protein Degradation and Inhibitors.
ADAR1 downregulation by autophagy drives senescence independently of RNA editing by enhancing p16INK4a levels
The FENDRR/FOXC2 Axis Contributes to Multidrug Resistance in Gastric Cancer and Correlates With Poor Prognosis
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy
NAD+ metabolism governs the proinflammatory senescence-associated secretome
Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference
Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers
BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
RETRACTED ARTICLE: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance
Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers
Comprehensive analysis of the ubiquitinome during oncogene-induced senescence in human fibroblasts
SUZ12 Promotes Human Epithelial Ovarian Cancer by Suppressing Apoptosis via Silencing HRK